title: Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials.
authors.affiliation: Biological Sciences Platform, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.
authors.forename: Robert S
authors.initials: RS
authors.lastname: Kerbel
authors.affiliation: Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
authors.forename: Axel
authors.initials: A
authors.lastname: Grothey
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male